biosimilardevelopment.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Robots.txt # Tells curious robots to go away # we should update this when we want to let robots in for the home page # and for news and storefronts user-agent: * disallow: /user/ disallow: /user-consent/status disallow: /User/ disallow: /usersession/ disallow: /UserSession/ disallow: /lead/ disallow: /Lead/ disallow: /nl* disallow: /submit disallow: /search disallow: /Search disallow: /buyersguide/ disallow: /BuyersGuide/ disallow: /content/rfp/ disallow: /content/associations/ disallow: /content/careercenter/ disallow: /content/membership/ disallow: /education/ disallow: /regform/ disallow: /rfq/ disallow: /RFQ/ disallow: /unifiedshoppingcart/ disallow: /unifiedShoppingCart/ disallow: /content/vertpages/ disallow: /any disallow: /Any disallow: /companies disallow: /bizsolution disallow: /read disallow: /Read disallow: /welcome disallow: /content/partner/ disallow: /registration/newsletter/ disallow: /Registration/Newsletter/ disallow: /storefronts/ disallow: /track/ disallow: | ||
Meta Tags
| Title | Biosimilar |
| Description | GUEST Get more biosimilar development insight with our FREE newsletter sign me up Log In or Subscribe Home Development Manufacturing Regulatory Editorial Board |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 20.185.12.70 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
biosimilardevelopment.com Valuation
|
US$2,771,535
Last updated: 2023-04-27 08:45:35
biosimilardevelopment.com has Semrush global rank of 3,818,932. biosimilardevelopment.com has an estimated worth of US$ 2,771,535, based on its estimated Ads revenue. biosimilardevelopment.com receives approximately 319,793 unique visitors each day. Its web server is located in United States, with IP address 20.185.12.70. According to SiteAdvisor, biosimilardevelopment.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,771,535 |
| Daily Ads Revenue | US$2,559 |
| Monthly Ads Revenue | US$76,751 |
| Yearly Ads Revenue | US$921,003 |
| Daily Unique Visitors | 21,320 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| biosimilardevelopment.com. 3600 | A | biosimilardevelopment.com. 3600 | IP: 20.185.12.70 |
| biosimilardevelopment.com. 86400 IN | NS | NS Record: ns-366.awsdns-45.com. | |
| biosimilardevelopment.com. 86400 IN | NS | NS Record: ns-538.awsdns-03.net. | |
| biosimilardevelopment.com. 86400 IN | NS | NS Record: ns-1414.awsdns-48.org. | |
| biosimilardevelopment.com. 86400 IN | NS | NS Record: ns-1785.awsdns-31.co.uk. | |
| biosimilardevelopment.com. 86400 IN | MX | MX Record: 0 biosimilardevelopment-com.mail.protection.outlook.com. | |
| biosimilardevelopment.com. 3600 | TXT | biosimilardevelopment.com. 3600 | TXT Record: v=spf1 a ip4:137.117.93.89 include:spf.protection.outlook.com include:mktomail.com -all |
HtmlToTextCheckTime:2023-04-27 08:45:35
| Get more biosimilar development insight with our FREE newsletter sign me up Log In or Subscribe Home Development Manufacturing Regulatory Editorial Board 5 Characteristics Of The Automated Microbiology Lab Of The Future The modern microbiology laboratory is starting to look very different from the laboratory of 10 years ago, and it will continue to evolve in the next few years. There are a number of innovations being implemented now or are in progress that can signal the path that many microbiology laboratories will follow. Risk-Based Strategies For Revalidating Bio/Pharma Equipment & Systems 4 Risk Mitigation Strategies For Procuring Custom Raw Materials For mRNA Production The Global Market For Generics & Biosimilars Through 2032 New DSCSA Compliance Blueprint Includes FDA & Industry Input Final Guidance Locks In FDA’s Definitions For Suspect And Illegitimate Drug Product A Regulator Looks Back On What We Learned From Accelerated SARS-CoV-2 Neutralizing mAbs Development Increase In |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 248 Content-Type: text/html Location: https://www.biosimilardevelopment.com/ Server: Microsoft-IIS/10.0 Date: Wed, 20 Oct 2021 13:56:50 GMT Connection: close HTTP/2 200 cache-control: no-cache, no-store pragma: no-cache content-type: text/html; charset=utf-8 server: Microsoft-IIS/10.0 strict-transport-security: max-age=2592000 set-cookie: .AspNetCore.Antiforgery.nXaQk3Q22eM=CfDJ8L4Tx_kqk_hOqQdWmadsynQZRtJOY4VUY_965YY-iUVyHoAUDjszL-vTUAVswLa3kqZUvi5NYzWyiZqOk0ns9oea0VCBj704wJnY80Yn8ZvcL54QoErJd2X-C45NYNWSRspe9oiGFz_2jmW5l2L4qNc; path=/; samesite=strict; httponly set-cookie: .AspNetCore.Mvc.CookieTempDataProvider=; expires=Thu, 01 Jan 1970 00:00:00 GMT; path=/; samesite=lax; httponly x-frame-options: SAMEORIGIN date: Wed, 20 Oct 2021 13:56:51 GMT |
biosimilardevelopment.com Whois Information
Domain Name: BIOSIMILARDEVELOPMENT.COM Registry Domain ID: 1924655701_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-04-26T05:23:50Z Creation Date: 2015-04-30T13:50:33Z Registry Expiry Date: 2023-04-30T13:50:33Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1414.AWSDNS-48.ORG Name Server: NS-1785.AWSDNS-31.CO.UK Name Server: NS-366.AWSDNS-45.COM Name Server: NS-538.AWSDNS-03.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T03:26:03Z <<< |